Welcome to AlzeCure Pharma’s website. In order to optimize your use of our website we use cookies. If you want more information about our cookie policy, please read more here. By continuing, you agree to our use of cookies.

OK

AlzeCure Pharma logo

Loading..
Svenska
Svenska
  • Home
  • About us
    About us
      • AlzeCure Pharma in brief
      • Vision and strategy
      • Organization
        • Management team
        • Board of directors
        • Founders
        • Scientific advisors
        • Partners
      • History
      • Career
  • Research & development
    Research & development
      • Project portfolio
      • NeuroRestore
      • Alzstatin
      • Alzheimer’s disease
      • Painless
        • ACD440
        • TrkA-NAM
      • Pain
      • Publications
  • Governance
    Governance
      • Corporate Governance Reports
      • General meeting
        • General meetings
      • Nomination Committee
      • Board of directors
      • Management team
      • Remuneration
      • Auditors
      • Articles of association
  • Investors
    Investors
      • AlzeCure Pharma on First North Premier Growth Market
        • Certified Adviser
      • Listing First North Premier
        • Prospectus
      • The share
        • Trading information
        • Sharecapital development
        • Dividend policy
        • Ownership structure
        • Monitoring
      • Financial reports
      • Financial calendar
      • Subscribe
      • Contact
  • Media
    Media
      • Press releases
      • Presentations and Interviews
      • Videos
      • Image bank
        • Board of directors
        • Management
        • Founders
        • Logotype
      • Financial calendar
      • Subscribe
      • Contact
  • Contact
    Contact
      • Office
      • Investors
      • Media

Media

Mikael Widell
Mikael Widell
Head of Communications and IR
mikael.widell@alzecurepharma.com
+46 703 11 99 60
Share
  • Contact
    • Office
    • Investors
    • Media

Subscribe

Read more about our protection of your personal data.
About us
  • AlzeCure Pharma in brief
  • Vision and strategy
  • Organization
  • Career
  • History
Research & development
  • Project portfolio
  • NeuroRestore
  • Alzstatin
  • Alzheimer’s disease
  • Painless
  • Pain
  • Publications
Governance
  • Corporate Governance Reports
  • General meeting
  • Nomination Committee
  • Board of directors
  • Management team
  • Remuneration
  • Auditors
  • Articles of association
Investors
  • AlzeCure Pharma on First North Premier Growth Market
  • Listing on First North Premier
  • The share
  • Financial reports
  • Financial calendar
  • Subscribe
  • Contact
Media
  • Press releases
  • Presentations and Interviews
  • Videos
  • Image bank
  • Financial calendar
  • Subscribe
  • Contact
Contact
  • Office
  • Investors
  • Media

AlzeCure Pharma AB, Hälsovägen 7,  SE-141 57 Huddinge, Sweden. Registration number: 559094-8302.

  • About cookies
  • Privacy policy